Loading clinical trials...
Loading clinical trials...
A Single Arm Trial of Adjuvant Pembrolizumab in Patients With Limited Stage Small Cell Lung Cancer
Conditions
Interventions
Cisplatin
Carboplatin
+7 more
Locations
1
United States
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, United States
Start Date
February 14, 2024
Primary Completion Date
May 27, 2025
Completion Date
May 27, 2025
Last Updated
June 5, 2025
NCT06498635
NCT05281237
NCT06122064
NCT05334069
NCT04751747
NCT05502523
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions